Related Experiment Video
Updated: Jan 24, 2026
10:18
From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
Published on: October 19, 2014
14.2K
Growth dynamics in naturally progressing chronic lymphocytic leukaemia
Michaela Gruber1,2,3,4, Ivana Bozic5, Ignaty Leshchiner2
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Nature
|May 31, 2019
Summary
Chronic lymphocytic leukemia (CLL) growth patterns, including exponential and logistic, are linked to distinct genomic features and disease progression. Genetic events present early influence later disease dynamics.
Area of Science:
- Hematology
- Genomics
- Cancer Biology
Background:
- The relationship between cancer genomic features and individual disease kinetics is not well understood.
- Chronic lymphocytic leukemia (CLL) exhibits indolent growth, making it a model for studying cancer kinetics.
Purpose of the Study:
- To analyze the growth rates and genomic patterns of leukemia cells in patients with CLL.
- To understand how genomic features influence disease kinetics and clonal evolution in CLL.
Main Methods:
- Analysis of leukemia cell growth rates and genomic patterns from 107 CLL patients over decades.
- Utilized next-generation sequencing on serial samples to track dynamic genetic changes.
- Quantified the in vivo growth advantage of subclones conferred by CLL driver mutations.
Main Results:
- CLL exhibits both exponential and logistic (sigmoidal) growth patterns.
- Distinct growth patterns correlate with differences in genetic composition, disease progression pace, and clonal evolution.
- Early genetic events shape the dynamic changes in CLL disease course.
Conclusions:
- Cancer genomic features significantly impact individual disease kinetics in CLL.
- Understanding these relationships can provide insights into disease progression and evolution.
- The study quantifies the in vivo impact of specific genetic drivers on leukemia cell growth.
Related Concept Videos
01:10Nature and Nurture
22.2K
Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
22.2K
01:32What is Natural Selection?
126.4K
Natural selection is an evolutionary process in which individuals with survival-promoting traits reproduce at higher rates. These favorable traits become more common within a population or species. Naturally selected traits initially arise via random genetic mutations. In order for selection to occur, there must be variation within a population, the trait controlling the variation must be heritable, and there must be an evolutionary advantage for variation in the trait.
126.4K
00:57Population Growth
28.1K
Population size is dynamic, increasing with birth rates and immigration, and decreasing with death rates and emigration. In ideal conditions with unlimited resources, populations can increase exponentially, which plots as a J-shaped growth rate curve of population size against time. This type of curve is characteristic of newly-introduced invasive species, or populations that have suffered catastrophic declines and are rebounding.
28.1K
02:20Dynamic Equilibrium
62.0K
A reversible chemical reaction represents a chemical process that proceeds in both forward (left to right) and reverse (right to left) directions. When the rates of the forward and reverse reactions are equal, the concentrations of the reactant and product species remain constant over time and the system is at equilibrium. A special double arrow is used to emphasize the reversible nature of the reaction. The relative concentrations of reactants and products in equilibrium systems vary greatly;...
62.0K
02:07Tumor Progression
7.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.3K
03:03mTOR Signaling and Cancer Progression
4.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.7K